Meriç A. Altinoz

1.7k total citations
89 papers, 1.2k citations indexed

About

Meriç A. Altinoz is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Meriç A. Altinoz has authored 89 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 27 papers in Genetics and 16 papers in Cancer Research. Recurrent topics in Meriç A. Altinoz's work include Glioma Diagnosis and Treatment (18 papers), Estrogen and related hormone effects (10 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Meriç A. Altinoz is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Estrogen and related hormone effects (10 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Meriç A. Altinoz collaborates with scholars based in Türkiye, Netherlands and United States. Meriç A. Altinoz's co-authors include İlhan Elmacı, Aysel Özpınar, Ayhan Bılır, Alp Ozpinar, Ebru Emekli‐Alturfan, Emily Hacker, Aydın Sav, Sinan Gülöksüz, Rolando F. Del Maestro and Ahmet Hacımüftüoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Meriç A. Altinoz

84 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meriç A. Altinoz Türkiye 21 532 217 165 139 112 89 1.2k
Sébastien Chateauvieux Luxembourg 20 678 1.3× 153 0.7× 183 1.1× 142 1.0× 93 0.8× 22 1.3k
Chul Won Yun South Korea 20 660 1.2× 192 0.9× 129 0.8× 120 0.9× 46 0.4× 28 1.1k
Jing Ma China 23 656 1.2× 201 0.9× 94 0.6× 233 1.7× 93 0.8× 73 1.4k
Caiping Chen China 21 782 1.5× 215 1.0× 100 0.6× 214 1.5× 99 0.9× 68 1.5k
Ashutosh Shrivastava India 15 458 0.9× 162 0.7× 93 0.6× 114 0.8× 42 0.4× 61 1.1k
Kai Zhao China 23 748 1.4× 360 1.7× 155 0.9× 220 1.6× 51 0.5× 107 1.6k
Xiang Lv China 22 1.2k 2.2× 328 1.5× 109 0.7× 165 1.2× 109 1.0× 83 1.8k
Lauren Diebold United States 13 1.0k 1.9× 356 1.6× 127 0.8× 130 0.9× 82 0.7× 14 1.7k
Muralidharan Anbalagan United States 24 688 1.3× 220 1.0× 144 0.9× 390 2.8× 190 1.7× 57 1.6k
Huifang Li China 19 552 1.0× 122 0.6× 115 0.7× 173 1.2× 176 1.6× 77 1.3k

Countries citing papers authored by Meriç A. Altinoz

Since Specialization
Citations

This map shows the geographic impact of Meriç A. Altinoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meriç A. Altinoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meriç A. Altinoz more than expected).

Fields of papers citing papers by Meriç A. Altinoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meriç A. Altinoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meriç A. Altinoz. The network helps show where Meriç A. Altinoz may publish in the future.

Co-authorship network of co-authors of Meriç A. Altinoz

This figure shows the co-authorship network connecting the top 25 collaborators of Meriç A. Altinoz. A scholar is included among the top collaborators of Meriç A. Altinoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meriç A. Altinoz. Meriç A. Altinoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hacıoğlu, Ayşa, Meriç A. Altinoz, Gazanfer Ekinci, et al.. (2025). Rathke’s cleft cyst: From history to molecular genetics. Reviews in Endocrine and Metabolic Disorders. 26(2). 229–260. 3 indexed citations
2.
Altinoz, Meriç A., Muhittin A. Serdar, Mustafa Eroğlu, et al.. (2025). ω9 Monounsaturated and Saturated Colostrum Fatty Acids May Benefit Newborns in General and Subtle Hypothyroid Stages. Nutrients. 17(12). 2017–2017. 1 indexed citations
3.
Altinoz, Meriç A., Alp Ozpinar, Emily Hacker, & Aysel Özpınar. (2022). A hypothetical proposal to employ meperidine and tamoxifen in treatment of glioblastoma. Role of P-glycoprotein, ceramide and metabolic pathways. Clinical Neurology and Neurosurgery. 215. 107208–107208. 4 indexed citations
4.
Altinoz, Meriç A. & Aysel Özpınar. (2022). Oxamate targeting aggressive cancers with special emphasis to brain tumors. Biomedicine & Pharmacotherapy. 147. 112686–112686. 42 indexed citations
5.
6.
Altinoz, Meriç A., et al.. (2020). Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity. Cancer Medicine. 9(16). 5767–5780. 12 indexed citations
7.
Kumar, Dileep, et al.. (2020). Mechanisms of Colorectal Cancer Prevention by Aspirin—A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways. International Journal of Molecular Sciences. 21(23). 9018–9018. 43 indexed citations
8.
Elmacı, İlhan, Meriç A. Altinoz, Gökhan Akdemir, et al.. (2020). Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case. Clinical Neurology and Neurosurgery. 200. 106342–106342. 6 indexed citations
9.
Altinoz, Meriç A., et al.. (2019). Methenamine's journey of 160 years: Repurposal of an old urinary antiseptic for treatment and hypoxic radiosensitization of cancers and glioblastoma. Clinical and Experimental Pharmacology and Physiology. 46(5). 407–412. 11 indexed citations
10.
Altinoz, Meriç A. & Aysel Özpınar. (2019). PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism. International Immunopharmacology. 69. 245–256. 45 indexed citations
11.
Elmacı, İlhan, et al.. (2017). Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors: A Short Review. Applied immunohistochemistry & molecular morphology. 26(9). 627–631. 46 indexed citations
12.
Altinoz, Meriç A., et al.. (2017). Hemoglobins emerging roles in mental disorders. Metabolical, genetical and immunological aspects. International Journal of Developmental Neuroscience. 61(1). 73–85. 14 indexed citations
13.
Altinoz, Meriç A., Sinan Gülöksüz, & İlhan Elmacı. (2017). Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential. Clinical & Translational Oncology. 19(7). 785–792. 11 indexed citations
14.
Elmacı, İlhan & Meriç A. Altinoz. (2016). A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme. Biochemical Genetics. 54(5). 573–618. 39 indexed citations
15.
Altinoz, Meriç A., et al.. (2016). Prepontine Chordoma Presenting with MRI Features of an Epidermoid Cyst: Case Presentation and a Mini-Review. Current Medical Imaging Formerly Current Medical Imaging Reviews. 14(1). 147–150. 4 indexed citations
16.
Altinoz, Meriç A., et al.. (2015). Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?. Clinical & Translational Oncology. 18(1). 9–17. 1 indexed citations
17.
18.
19.
Altinoz, Meriç A., et al.. (2006). Medroxyprogesterone and tamoxifen augment anti‐proliferative efficacy and reduce mitochondria‐toxicity of epirubicin in FM3A tumor cells in vitro. Cell Biology International. 31(5). 473–481. 13 indexed citations
20.
Bılır, Ayhan, et al.. (2000). Culturability of osteoblast cells extracted from mature and fetal BALB/c mice calvaria. Acta Orthopaedica et Traumatologica Turcica. 34(4). 389–395. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sébastien Chateauvieux Breakdown of academic impact, for papers by Chul Won Yun Breakdown of academic impact, for papers by Jing Ma Breakdown of academic impact, for papers by Caiping Chen Breakdown of academic impact, for papers by Ashutosh Shrivastava Breakdown of academic impact, for papers by Kai Zhao Breakdown of academic impact, for papers by Xiang Lv Breakdown of academic impact, for papers by Lauren Diebold Breakdown of academic impact, for papers by Muralidharan Anbalagan Breakdown of academic impact, for papers by Huifang Li
Rankless by CCL
2026